Survivors of Ireland’s mother and baby homes can continue to receive benefits in the UK after Downing Street dropped a plan to cut payments. Keir Starmer bowed to pressure from campaigners to back a bill known as Philomena’s law, which would ringfence survivors’ benefits if they accepted compensation from Dublin. Up to 13,000 of the survivors who are living in Britain risked losing access to essen...
Survivors of Ireland’s mother and baby homes can continue to receive benefits in the UK after Downing Street dropped a plan to cut payments. Keir Starmer bowed to pressure from campaigners to back a bill known as Philomena’s law, which would ringfence survivors’ benefits if they accepted compensation from Dublin. Up to 13,000 of the survivors who are living in Britain risked losing access to essential means-tested benefits if they accepted compensation, which can range from €5,000 to €125,000 (£4,230 to £105,000) depending on the length of time people were resident. In a joint statement, the British and Irish governments acknowledged the victims’ suffering. “In recognition of the lifelong impact of this, today the UK agrees to disregard payments under Ireland’s mother and baby redress scheme, ensuring that survivors in both countries are treated the same and can receive the compensation to which they are rightly entitled.” The decision followed an Anglo-Irish summit with Starmer and the taoiseach, Micheál Martin. Campaigners including the actors Siobhán McSweeney and Steve Coogan had urged the government to back Philomena’s law, which was introduced in parliament by the Labour MP Liam Conlon. “This was about more than redress payments,” said Conlon, who welcomed the news. “It was also about ensuring that we tackle the stigma and shame that have wrongly followed so many women and their children for so long, and about showing thousands of survivors the kindness and dignity they have so often been denied throughout their lives.” Philomena Lee, a survivor, said no amount of money could undo the pain or give back what was taken from so many women. “But recognition, accountability and redress do matter, and no survivor should ever be penalised for accepting the compensation they are rightfully owed,” she said. Lee’s story of forced separation from – and her later search for her lost son –inspired the Oscar-nominated Philomena starring Coogan and Judi Dench. She thanked Co...
In a move that has electrified the semiconductor sector, Wedbush Securities analyst Matt Bryson significantly raised the price target for Micron Technology (NASDAQ: MU) to $500 from $320 on March 13, 2026. This bold adjustment represents the highest valuation on Wall Street for the Boise-based memory giant, signaling a belief that the memory industry is no longer merely cyclical but is undergoing ...
In a move that has electrified the semiconductor sector, Wedbush Securities analyst Matt Bryson significantly raised the price target for Micron Technology (NASDAQ: MU) to $500 from $320 on March 13, 2026. This bold adjustment represents the highest valuation on Wall Street for the Boise-based memory giant, signaling a belief that the memory industry is no longer merely cyclical but is undergoing a structural transformation driven by the insatiable needs of artificial intelligence (AI) infrastructure. The upgrade comes at a time when Micron’s stock is trading in the $415–$430 range, buoyed by a "V-shaped" recovery in margins and a supply-demand imbalance that shows no signs of easing. As tech giants continue their multibillion-dollar investments into AI data centers, Wedbush asserts that Micron has established a "Memory Fortress," with its high-end capacity effectively sold out for the remainder of the 2026 calendar year and order books already filling for 2027. Structural Shift: The Path to $500 The dramatic price target hike from Wedbush is the culmination of a momentum-filled six-month period for Micron. In mid-December 2025, Bryson had already raised his target to $300, but the sheer velocity of memory pricing gains in the first quarter of 2026 forced a major reassessment. According to Wedbush’s industry checks, contract pricing for dynamic random-access memory (DRAM) and NAND flash memory surged by over 50% in the first ten weeks of 2026 alone. Unlike previous years where a post-Chinese New Year lull was expected, the market saw triple-digit percentage increases for specific high-density memory modules. This "unprecedented" pricing power is largely attributed to the scarcity of High Bandwidth Memory (HBM), specifically the HBM3E and nascent HBM4 generations. HBM is critical for powering GPUs like those produced by Nvidia (NASDAQ: NVDA), acting as the bridge that allows data to flow quickly enough for complex AI training. Because HBM sells for a premium of three...
alexsl Roth Capital Partners launched its coverage of Apellis Pharmaceuticals ( APLS ) with a Buy recommendation and a $31 target on Friday, noting that despite a ~75% decline from its 2023 peak, the biotech remains a compelling opportunity due to its lead asset, Syfovre. Apellis ( APLS ) shares came under pressure in July 2023 amid reports of eye inflammation (retinal vasculitis) linked to Syfovr...
alexsl Roth Capital Partners launched its coverage of Apellis Pharmaceuticals ( APLS ) with a Buy recommendation and a $31 target on Friday, noting that despite a ~75% decline from its 2023 peak, the biotech remains a compelling opportunity due to its lead asset, Syfovre. Apellis ( APLS ) shares came under pressure in July 2023 amid reports of eye inflammation (retinal vasculitis) linked to Syfovre, an intravitreal medication approved about a year ago for an eye disorder known as geographic atrophy. “The market's reaction to the vasculitis signal was appropriate at the time,” analyst Adam Walsh wrote. “A newly approved therapy with an emerging safety signal in a disease with an alternative treatment warranted caution, and physician self-selection to competing therapy was a rational response.” However, Walsh noted that the company holds about a 60% market share for Syfovre in GA, and its injection volumes climbed 17% in FY25 while concerns over vasculitis “meaningfully diminished.” The analyst projects above-consensus revenue estimates for the company in FY27, citing accelerated adoption for Syfovre, starting from that year, due to the launch of a prefilled syringe and a functional imaging tool that can expand the GA market. Walsh estimates $1.2B of peak revenue for Syfovre in FY34, 30% above the consensus. More on Apellis Pharmaceuticals Apellis Pharmaceuticals, Inc. (APLS) Presents at TD Cowen 46th Annual Health Care Conference Transcript Apellis Pharmaceuticals, Inc. (APLS) Q4 2025 Earnings Call Transcript Apellis Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation Apellis Pharmaceuticals reports Q4 results Apellis Pharmaceuticals Q4 2025 Earnings Preview
Consumer discretionary businesses are levered to the highs and lows of economic cycles. This sensitive demand profile can cause discretionary stocks to plummet when macro uncertainty enters the fray, and over the past six months, the industry has shed 9.8%. This drawdown is a far cry from the S&P 500’s 2.3% ascent. Despite the lackluster result, a few diamonds in the rough can produce earnings gro...
Consumer discretionary businesses are levered to the highs and lows of economic cycles. This sensitive demand profile can cause discretionary stocks to plummet when macro uncertainty enters the fray, and over the past six months, the industry has shed 9.8%. This drawdown is a far cry from the S&P 500’s 2.3% ascent. Despite the lackluster result, a few diamonds in the rough can produce earnings growth no matter what, and we started StockStory to help you find them. Keeping that in mind, here is one consumer stock boasting a durable advantage and two we’re steering clear of. Two Consumer Discretionary Stocks to Sell: YETI (YETI) Market Cap: $2.72 billion Founded by two brothers from Texas, YETI (NYSE:YETI) specializes in durable outdoor goods including coolers, drinkware, and other gear tailored to adventure enthusiasts. Why Should You Sell YETI? Annual revenue growth of 11.3% over the last five years was below our standards for the consumer discretionary sector Forecasted free cash flow margin suggests the company will fail to improve its cash conversion over the next year Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned At $36.45 per share, YETI trades at 13.4x forward P/E. To fully understand why you should be careful with YETI, check out our full research report (it’s free). The Real Brokerage (REAX) Market Cap: $524.4 million Founded in Toronto, Canada in 2014, The Real Brokerage (NASDAQ:REAX) is a technology-driven real estate brokerage firm combining a tech-centric model with an agent-centric philosophy. Why Do We Think REAX Will Underperform? Poor expense management has led to an operating margin of -0.8% that is below the industry average Earnings growth over the last four years fell short of the peer group average as its EPS only increased by 8.9% annually Free cash flow margin is not anticipated to grow over the next year The Real Brokerage’s stock price of $2.47 imp...
primeimages/E+ via Getty Images Portfolio management Andy Acker, CFA Daniel Lyons, Ph.D., CFA Investment environment Healthcare stocks were the top-performing sector during the fourth quarter, buoyed by steadfast innovation, growing relief over tariff concerns and drug pricing, and accommodative Federal Reserve (Fed) policy, which helped spur mergers and acquisitions (M&A) activity. Pharmaceutical...
primeimages/E+ via Getty Images Portfolio management Andy Acker, CFA Daniel Lyons, Ph.D., CFA Investment environment Healthcare stocks were the top-performing sector during the fourth quarter, buoyed by steadfast innovation, growing relief over tariff concerns and drug pricing, and accommodative Federal Reserve (Fed) policy, which helped spur mergers and acquisitions (M&A) activity. Pharmaceuticals led performance, as optimism was lifted by the early October deal between Pfizer ( PFE ) and the U.S. administration to focus discounts on limited channels like Medicaid for a few legacy drugs. In addition, concerns about tariffs were alleviated by commitments to invest in U.S. manufacturing, followed by arrangements with several other key drug companies on similar terms. Other policy directives, such as agreements to significantly reduce the price of obesity drugs for Medicare and Medicaid beneficiaries while improving patient access, also contributed to positive sentiment. Notable approvals during the quarter included Novo Nordisk’s ( NVO ) once-daily oral version of semaglutide to manage obesity, the first alternative to injections in this indication; and Otsuka’s Voyxact, to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN), a chronic kidney disease. Johnson & Johnson’s ( JNJ ) Darzalex also became the first drug to be indicated for smoldering multiple myeloma, a blood and bone marrow disorder that can become the rare blood cancer, active multiple myeloma. In biotech, approvals included aficamten for a form of heart disease and Uplizna for myasthenia gravis, a chronic neuromuscular disease. And under the new National Priority Review Voucher pilot program, the FDA granted speedy review to Johnson & Johnson’s proposed combination of Tecvayli and Darzalex for previously treated multiple myeloma. Following three successive rate cuts by the Fed and upcoming patent cliffs faced by large pharmaceutical companies, deal activity was active. Novo Nor...
Weekend At Bernie's In Iran As IRGC Now Run The Country, Use Strait As Toll Road By Ben Picton, senior market strategist at Rabobank Mine, Yours Major US, European and Asian equity indices all closed in the red yesterday as Brent crude prices again breached the $100/bbl level. Ten year sovereign yields were sharply higher for most countries (Sweden being an exception), with UK Gilts conspicuous fo...
Weekend At Bernie's In Iran As IRGC Now Run The Country, Use Strait As Toll Road By Ben Picton, senior market strategist at Rabobank Mine, Yours Major US, European and Asian equity indices all closed in the red yesterday as Brent crude prices again breached the $100/bbl level. Ten year sovereign yields were sharply higher for most countries (Sweden being an exception), with UK Gilts conspicuous for posting an 8.7bps increase. Short end yields rose even faster as markets priced in higher policy rate paths. Canadian two year yields were up 9.8bps and in New Zealand yields rose 10.1bps. Canada now has 41bps worth of policy rate hikes priced into the forward curve for this year and New Zealand has 77bps priced. Prior to the outbreak of war, the market was still pricing cuts in Canada and it was still seen as uncertain that the RBNZ would be raising rates at all in 2026. Market bets on Fed rate cuts this year are evaporating fast. Market optimism following Donald Trump’s comment earlier this week that the war is “very complete” and news that the G7 will coordinate on the release of 400mn barrels from strategic reserves appears to have been short-lived. Iranian Supreme Leader Khamenei ( the new one ) has issued his first public statement, in which he echoed previous IRGC vows to keep the Strait of Hormuz closed. There was a bit of a ‘ Weekend at Bernie’s’ vibe about this as Khamenei himself did not appear on camera . Rumors that he was injured – perhaps severely – in the opening strikes of the war are now circulating alongside suggestions that the Iranian Revolutionary Guard Corps are now running the country and that Khamenei is being used as a convenient figurehead to give the impression of continuity under external pressure. Despite Khamenei’s vow to keep the Strait closed market pricing is still signalling optimism that the war will be relatively short – although this optimism waned somewhat over the last 24 hours. Prediction markets have a ceasefire before month end a...
Iran has arranged special transportation to return about 180 sailors from India, according to a person familiar with the matter. Most of the 180 Iranian sailors will fly back from the southern Indian city of Kochi, the person said, requesting not be identified as the matter is sensitive. Iran is also bringing back the bodies of sailors who lost their lives after the US sank their ship off the coas...
Iran has arranged special transportation to return about 180 sailors from India, according to a person familiar with the matter. Most of the 180 Iranian sailors will fly back from the southern Indian city of Kochi, the person said, requesting not be identified as the matter is sensitive. Iran is also bringing back the bodies of sailors who lost their lives after the US sank their ship off the coast of Sri Lanka, the person said. India’s Ministry of External Affairs, Ministry of Defense, and the Indian Navy didn’t immediately respond to a request for information after business hours. The development comes a week after a US submarine sank an Iranian warship off Sri Lanka’s coast, deepening the Middle East war and bringing it closer to India’s doorstep . Of the 130 people on board the Iranian frigate IRIS Dena, about 32 were saved and treated at a hospital, according to Sri Lankan officials. Dozens remain missing. India is negotiating with Iran for safe passage for its vessels as it grapples with an energy crisis that’s caused a shortage of cooking gas, sowing disruption across the country. On Saturday, India said it allowed an Iranian naval vessel to dock in its port, days before a frigate from the Persian Gulf nation was sunk by a US submarine. India’s External Affairs Minister, S. Jaishankar, has spoken four times in recent days with his Iranian counterpart, Abbas Araghchi to discuss issues related to safety of vessels of shipping and energy security. Read More: Killing of Modi’s Invited Iranian Guests Strains US-India Ties
The European Commission is set to suspend some duty-free sugar imports for “at least a year” to help stabilize prices within the bloc. The paperwork for the suspension is being prepared, Christophe Hansen , Commissioner for Agriculture and Food, said in an interview Friday. “In the next few weeks, it will be on the table.” The proposal pertains to the so-called inward processing regime for sugar, ...
The European Commission is set to suspend some duty-free sugar imports for “at least a year” to help stabilize prices within the bloc. The paperwork for the suspension is being prepared, Christophe Hansen , Commissioner for Agriculture and Food, said in an interview Friday. “In the next few weeks, it will be on the table.” The proposal pertains to the so-called inward processing regime for sugar, which allows duty-free imports if it is processed in the EU and then exported outside the region. The move comes amid pressure from local producers faced with lower prices The suspension “will be at least for one year,” Hansen said, adding that the bloc would assess how the pause will impact the domestic industry. “Currently there are 700,000 tons coming in. I think this will stabilize the market and the prices of European sugar.” Read More: EU Sugar Supply to Tighten as Farmers Plan Deeper Acreage Cuts
Brazil’s state-controlled oil giant Petroleo Brasileiro SA raised domestic diesel prices just a day after the Brazilian government announced federal tax breaks on fuels to shield consumers from surging crude prices. After holding diesel prices since a reduction in May, Petrobras announced a increase for distributors to 3.65 reais (69 cents) a liter from March 14, the company said Friday. Gasoline ...
Brazil’s state-controlled oil giant Petroleo Brasileiro SA raised domestic diesel prices just a day after the Brazilian government announced federal tax breaks on fuels to shield consumers from surging crude prices. After holding diesel prices since a reduction in May, Petrobras announced a increase for distributors to 3.65 reais (69 cents) a liter from March 14, the company said Friday. Gasoline prices were left unchanged. Read More: Brazil Cuts Fuel Tax to Offset Oil Price Surge as War Rages (1) Petrobras adopts a policy of not immediately passing on oil price volatility to customers. Chief Executive Officer Magda Chambriard vowed to wait and see if and for how long crude prices would remain elevated before pulling the price trigger. But the gap between Petrobras’s refinery gate prices and international levels has widened as crude approached $100 a barrel due to the Middle East war. Petrobras prices are 72% discounted for diesel and 43% for gasoline, according to Brazilian fuel importers association Abicom. Petrobras said in a statement that the last diesel price increase occurred more than a year ago, noting that the impact of the price adjustment on the final consumer is mitigated by the tax exemption announced Thursday.
Eoneren/E+ via Getty Images Investment thesis For crypto investors who believe in Bitcoin's ( BTC-USD ) growth potential, the start of 2026 has not been what they expected. Over the past 5 months, there has been a negative change in the price of the leading cryptocurrency, matching the record bear market of 2018-2019. Consequently, the dynamics of spot ETFs on Bitcoin, where the "gold standard" is...
Eoneren/E+ via Getty Images Investment thesis For crypto investors who believe in Bitcoin's ( BTC-USD ) growth potential, the start of 2026 has not been what they expected. Over the past 5 months, there has been a negative change in the price of the leading cryptocurrency, matching the record bear market of 2018-2019. Consequently, the dynamics of spot ETFs on Bitcoin, where the "gold standard" is the iShares Bitcoin Trust ETF ( IBIT ), is also negatively affected. The fundamental background remains negative, with the situation in Iran showing no signs of de-escalation, Bitcoin's price may attempt to continue its decline to complete a deep correction to the $50,000–$55,000 price zone. Nevertheless, my long-term objectives remain unchanged, with a renewed all-time high of $126,223. At the same time, it is not certain that the market has not already reversed, finding its cyclical bottom at $60,000. If we assume that the current price of Bitcoin at $69,000 will be the entry point for IBIT, the potential risk/reward ratio is 1 to 4, in my opinion, a cost-effective bet on the fundamental growth of the cryptocurrency's value. Given this, my rating for IBIT remains at "Buy", because the current price of Bitcoin provides a favorable entry point into the market with a high risk-reward ratio. My Previous Thesis and Main Arguments I compared this fund with its main competitor among option players , NEOS Bitcoin High Income ETF ( BTCI ). The main point was that if the market moves into a phase of Bitcoin recovery growth, then IBIT will do better than the BTCI options mix, where some of the profits get cut off when the price goes up aggressively. In addition, earlier I believed that in 2026 we would see a potential renewal of Bitcoin's historical high, reaching a price range of $130,000-$150,000. The actual results turned out to be different, and since then, IBIT has shown a negative return of -11.57%. This downward movement in the cryptocurrency market is mainly driven by the p...
Elon Musk has ordered another round of job cuts at xAI after growing frustrated with the poor performance of its coding product, forcing Upgrade to read this Financial Times article and get so much more. A Silver or Gold subscription plan is required to access premium news articles.
Elon Musk has ordered another round of job cuts at xAI after growing frustrated with the poor performance of its coding product, forcing Upgrade to read this Financial Times article and get so much more. A Silver or Gold subscription plan is required to access premium news articles.
JHVEPhoto/iStock Editorial via Getty Images Article Thesis Micron Technology, Inc. ( MU ) will report its upcoming earnings results next week, on March 18th. Thanks to the massive tailwinds for the memory industry from the ongoing Artificial Intelligence boom, Micron will show strong revenue and earnings growth, and I believe that there is a good chance that Micron will outperform expectations onc...
JHVEPhoto/iStock Editorial via Getty Images Article Thesis Micron Technology, Inc. ( MU ) will report its upcoming earnings results next week, on March 18th. Thanks to the massive tailwinds for the memory industry from the ongoing Artificial Intelligence boom, Micron will show strong revenue and earnings growth, and I believe that there is a good chance that Micron will outperform expectations once again. Shares have soared over the last year, but are not looking expensive based on current profit estimates. Past Coverage I have written about Micron Technology here on Seeking Alpha in the past, most recently in September 2025, around half a year ago, when I published this article . I covered Micron Technology's fiscal Q4 results back then, noting its compelling business growth that has accelerated further since that article was published on the back of soaring memory prices. With Micron reporting its fiscal Q2 results next week, I want to update my views on the company and provide an earnings outlook for Micron. Micron's Upcoming Earnings: Strong Growth Expected We may not yet know the exact results that Micron Technology will report next Wednesday, but one thing seems pretty clear -- Micron will report huge growth for both its revenues and its earnings. Analysts are currently predicting that Micron will report a top-line result of $19.1 billion, which would mean an increase of 138% compared to one year earlier -- that's even better than the growth rate that AI king Nvidia ( NVDA ) has been delivering in recent quarters. A growth rate of almost 140% also compares very favorably to what other big tech companies, including the other six Magnificent 7 companies, have been achieving lately. I also think that it is very noteworthy that a growth rate of north of 130%, relative to one year earlier, would mean a major growth acceleration compared to what we have seen in the last couple of quarters: In fiscal Q1, Micron's revenues were up by 57% versus one year earlier, while...
JHVEPhoto/iStock Editorial via Getty Images Article Thesis Micron Technology, Inc. ( MU ) will report its upcoming earnings results next week, on March 18th. Thanks to the massive tailwinds for the memory industry from the ongoing Artificial Intelligence boom, Micron will show strong revenue and earnings growth, and I believe that there is a good chance that Micron will outperform expectations onc...
JHVEPhoto/iStock Editorial via Getty Images Article Thesis Micron Technology, Inc. ( MU ) will report its upcoming earnings results next week, on March 18th. Thanks to the massive tailwinds for the memory industry from the ongoing Artificial Intelligence boom, Micron will show strong revenue and earnings growth, and I believe that there is a good chance that Micron will outperform expectations once again. Shares have soared over the last year, but are not looking expensive based on current profit estimates. Past Coverage I have written about Micron Technology here on Seeking Alpha in the past, most recently in September 2025, around half a year ago, when I published this article . I covered Micron Technology's fiscal Q4 results back then, noting its compelling business growth that has accelerated further since that article was published on the back of soaring memory prices. With Micron reporting its fiscal Q2 results next week, I want to update my views on the company and provide an earnings outlook for Micron. Micron's Upcoming Earnings: Strong Growth Expected We may not yet know the exact results that Micron Technology will report next Wednesday, but one thing seems pretty clear -- Micron will report huge growth for both its revenues and its earnings. Analysts are currently predicting that Micron will report a top-line result of $19.1 billion, which would mean an increase of 138% compared to one year earlier -- that's even better than the growth rate that AI king Nvidia ( NVDA ) has been delivering in recent quarters. A growth rate of almost 140% also compares very favorably to what other big tech companies, including the other six Magnificent 7 companies, have been achieving lately. I also think that it is very noteworthy that a growth rate of north of 130%, relative to one year earlier, would mean a major growth acceleration compared to what we have seen in the last couple of quarters: In fiscal Q1, Micron's revenues were up by 57% versus one year earlier, while...
Chinnapong/iStock Editorial via Getty Images Crypto stocks were gaining late Friday morning as Bitcoin and related cryptocurrency sell-offs could reportedly be entering their final phase. Bitcoin ( BTC-USD ) is on track to close the week ~9% higher, shrugging off the Middle East concerns impacting broader markets. Ethereum ( ETH-USD ) is set to add ~11%. The gains come alongside hopes of more cryp...
Chinnapong/iStock Editorial via Getty Images Crypto stocks were gaining late Friday morning as Bitcoin and related cryptocurrency sell-offs could reportedly be entering their final phase. Bitcoin ( BTC-USD ) is on track to close the week ~9% higher, shrugging off the Middle East concerns impacting broader markets. Ethereum ( ETH-USD ) is set to add ~11%. The gains come alongside hopes of more crypto-friendly regulation in the U.S. On March 11, the Securities and Exchange Commission and the Commodity Futures Trading Commission announced an MoU and coordination for "providing a fit-for-purpose regulatory framework for crypto assets and other emerging technologies", among other things. Last week, cryptocurrency investment products recorded inflows of $619M. The crypto sell-off could be entering its final phase, Bloomberg News reported , citing Brett Munster of Blockforce Capital. Munster tracks four measures to gauge where Bitcoin stands in its crash cycle. BTC seems to have already grazed the upper edge of what he considers a probable bottoming zone, the Friday, March 13, report noted. The majority of the drawdown appears to be behind us, and the asymmetry is shifting, he reportedly said, adding that a potential turnaround could come about mid-year. "Once selling pressure fades, even modest new inflows can move the market," the crypto fund manager who has invested through three prior boom-and-bust cycles reportedly told the news outlet. Crypto-linked stocks are trading higher on the back of the recent uptick in the prices of the digital assets. Notable moves as of Friday morning include: MARA Holdings ( MARA ) - ~14% higher Cipher Digital ( CIFR ) - ~10% higher Bitmine Immersion ( BMNR ) - ~8% higher CleanSpark ( CLSK ) - ~7.5% higher Bakkt ( BKKT ) - ~6% higher Strategy ( MSTR ) - ~5% higher IREN ( IREN ) - ~4.5% higher Riot Platforms ( RIOT ), Bullish ( BLSH ), Coinbase Global ( COIN ) - ~4% higher More on Bitcoin USD, Ethereum USD Ethereum Price Consolidates Above ...
iridi/iStock via Getty Images Foreword This article is one of 15 Dividend Dog collections featured in Seeking Alpha by this analyst, who tags himself the "Dividend Dogcatcher." I'm Fredrik Arnod, and as the Dividend Dogcatcher, I have devised a series of 15 keystone essays that change little, but for the essential graphic and statistical daily, weekly, monthly, quarterly, or annual data that suppo...
iridi/iStock via Getty Images Foreword This article is one of 15 Dividend Dog collections featured in Seeking Alpha by this analyst, who tags himself the "Dividend Dogcatcher." I'm Fredrik Arnod, and as the Dividend Dogcatcher, I have devised a series of 15 keystone essays that change little, but for the essential graphic and statistical daily, weekly, monthly, quarterly, or annual data that support a cadre of more than 30,000 followers. Those fifteen keystone Dogcatcher essays include the following indices and publications: S&P500 S&P600 Berkshire Hathaway Fortune 500 Kiplinger Reports Aristocrats Dividend Kings Barron’s Pro Picks ReFa/Ro Sustainables (Barron’s) Bloomberg Intelligence Power Dividends Ben Graham All Stars Monthly Pays Actionable Conclusions (1-10): Brokers Estimated Top 10 MoPay Equities Could Net 26.26% to 59.08% Gains By March, 2027 Four of ten top-yield MoPay stocks (shaded in the chart below) were also top-ten gainers for the coming year (based on analyst one-year targets). So, graded by broker estimates this month, Dogcatcher yield-based strategy proved 40% accurate: source: YCharts Stellus Capital Investment ( SCM ) netted $484.28 based on the median of target price estimates from five analysts, plus dividends. The Beta number showed this estimate subject to risk/volatility 33% less than the market as a whole. CION Investment ( CION ) netted $483.08 based on the median of target price estimates from three analysts, plus dividends, less broker fees. A Beta number was not available for CION. PennantPark Floating Rate Capital Ltd ( PFLT ) netted $424.73 based on target price estimates from seven analysts, plus dividends, and broker fees. The Beta number showed this estimate subject to risk/volatility 23% less than the market as a whole. BCP Investment ( BCIC ) netted $341.81 based on the median of target price estimates from 4 analysts, plus dividends, less broker fees. The Beta number showed this estimate subject to risk/volatility 60% under the...
"This is the culmination of what [Netanyahu] has tried to rebrand as the War of Redemption, which in his mind started on October 7, 2023. And this is - if not the last war - then the big war against Iran," said Neri Zilber, a journalist based in Tel Aviv and a policy advisor to the Israel Policy Forum, a US-Israeli think tank.
"This is the culmination of what [Netanyahu] has tried to rebrand as the War of Redemption, which in his mind started on October 7, 2023. And this is - if not the last war - then the big war against Iran," said Neri Zilber, a journalist based in Tel Aviv and a policy advisor to the Israel Policy Forum, a US-Israeli think tank.